Dual probe assay for the detection of HCV

Patent metadata

Field	Value
Publication number	US-9512494-B2
Application number	US-201314055698-A
Country	US
Kind code	B2
Filing date	Oct 16, 2013
Priority date	Oct 18, 2012
Publication date	Dec 6, 2016
Grant date	Dec 6, 2016

Abstract

The present invention relates to a method for amplifying and detecting a target nucleic acid of HCV in a sample, wherein an amplification of the nucleic acids in said sample is carried out. This amplification involves a polymerase, primers for generating an amplicon and at least two detectable probes specific for different sequence portions of said amplicon. Detection of the obtained amplicon is brought about by detecting hybridization of the probes mentioned above to said different sequence portions of the amplicon.
The invention further provides reaction mixtures and kits for amplifying and detecting a target nucleic acid of HCV involving the use of at least two detectable probes specific for different sequence portions of an amplicon.

First claim

The invention claimed is:

1. A kit for amplifying and detecting a target nucleic acid of HCV that may be present in a sample, said kit comprising amplification reagents comprising a DNA polymerase, nucleotide monomers, primers effective for generating an amplicon from said target nucleic acid, and at least two detectable probes that are labeled and specific for different sequence portions of said amplicon, wherein said detectable probes comprise at least two sequences selected from the group consisting of SEQ ID NOs:1 to 8 or the respective complements thereof, and wherein said primers are SEQ ID NOs:9, 10, and 11.

2. The kit of claim 1 , wherein said detectable probes do not overlap.

3. The kit of claim 1 , wherein said primers comprise more than one forward or reverse primer.

4. A reaction mixture for amplifying and detecting a target nucleic acid that may be present in a sample, said target nucleic acid comprising subgroups with sequence variations and/or individual mutations, said reaction mixture comprising a sample or portion of a sample, amplification reagents comprising a DNA polymerase, nucleotide monomers, primers effective for generating an amplicon from said target nucleic acid, and at least two detectable probes that are labeled and specific for different sequence portions of said amplicon, wherein said detectable probes comprise at least two sequences selected from the group consisting of SEQ ID NOs:1 to 8 or the respective complements thereof, and wherein said primers are SEQ ID NOs:9, 10, and 11.

5. The reaction mixture of claim 4 , wherein said detectable probes do not overlap.

6. The kit of claim 4 , wherein said primers comprise more than one forward or reverse primer.

Assignees

• Roche Molecular System Inc
• Roche Molecular Systems Inc

Inventors

• Bergmann Frank
• Sizmann Dorothea
• Zitzer Heike

Classifications

• C07H21/04

  with deoxyribosyl as saccharide radical · CPC title

• C12Q1/6816 Primary

  characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

• C12Q1/707 Primary

  non-A, non-B Hepatitis, excluding hepatitis D · CPC title

• C12Q2537/143

  Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title